Eton Pharmaceuticals, Inc. (ETON) on GreekSoup https://greeksoup.ai/stocks/us/eton/ Every dated entry in the public record on Eton Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Eton Pharmaceuticals, Inc.: short interest 1,943,339 shares at the 15 October 2026 settlement, 3.30 days to coverhttps://greeksoup.ai/stocks/us/eton/short-interest/us:ETON:short-interest:2026-10-15:6b9a72e003Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 8-K: material agreement, acquisition or disposition completedhttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-10-14:f8c6c236e2Wed, 14 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Form 144, Krempa David plans to sell 4,166 shares worth $229,406 around 6 October 2026https://greeksoup.ai/stocks/us/eton/planned-sales/us:ETON:planned-sale:2026-10-06:be0dc93163Tue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Krempa David (Chief Business Officer) sold 4,166 shares at $55.07 on 6 October 2026, $229,406https://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-10-06:c89688a2a7Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: short interest 1,834,090 shares at the 30 September 2026 settlement, 2.94 days to coverhttps://greeksoup.ai/stocks/us/eton/short-interest/us:ETON:short-interest:2026-09-30:41ae5afaaeWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-09-28:4ee7fff3fdMon, 28 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: short interest 1,542,982 shares at the 15 September 2026 settlement, 3.52 days to coverhttps://greeksoup.ai/stocks/us/eton/short-interest/us:ETON:short-interest:2026-09-15:a18c85b7f2Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: short interest 1,347,971 shares at the 31 August 2026 settlement, 1.98 days to coverhttps://greeksoup.ai/stocks/us/eton/short-interest/us:ETON:short-interest:2026-08-31:66b66c1b3fMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Form 144, MAIER PAUL V plans to sell 50,000 shares worth $3.0 million around 28 August 2026https://greeksoup.ai/stocks/us/eton/planned-sales/us:ETON:planned-sale:2026-08-28:38444d4dfcFri, 28 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Maier Paul V (Director) sold 36,387 shares at $58.64 on 28 August 2026, $2.1 millionhttps://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-28:7a578ceca6Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Maier Paul V (Director) sold 13,485 shares at $60.21 on 28 August 2026, $811,932https://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-28:1822dc48b1Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Maier Paul V (Director) sold 128 shares at $61.77 on 28 August 2026, $7,907https://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-28:19450b7110Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Form 144, Krempa David plans to sell 25,000 shares worth $1.6 million around 24 August 2026https://greeksoup.ai/stocks/us/eton/planned-sales/us:ETON:planned-sale:2026-08-24:d2cc1db38dMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Krempa David (Chief Business Officer) sold 25,000 shares at $65.07 on 24 August 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-24:ffa1af2ffbMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Brynjelsen Sean (President & CEO) sold 47,307 shares at $60.17 on 20 August 2026, $2.8 millionhttps://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-20:01ce59b1aeThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Brynjelsen Sean (President & CEO) sold 36,373 shares at $61.11 on 20 August 2026, $2.2 millionhttps://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-20:18dc42145fThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Brynjelsen Sean (President & CEO) sold 7,342 shares at $62.12 on 20 August 2026, $456,085https://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-20:80b71a241aThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Brynjelsen Sean (President & CEO) sold 8,978 shares at $62.65 on 19 August 2026, $562,472https://greeksoup.ai/stocks/us/eton/insiders/us:ETON:insider:2026-08-20:0390e19231Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: Form 144, BRYNJELSEN SEAN plans to sell 100,000 shares worth $6.3 million around 19 August 2026https://greeksoup.ai/stocks/us/eton/planned-sales/us:ETON:planned-sale:2026-08-19:a7c8b67884Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc.: short interest 1,427,797 shares at the 14 August 2026 settlement, 2.24 days to coverhttps://greeksoup.ai/stocks/us/eton/short-interest/us:ETON:short-interest:2026-08-14:72de923046Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. Q2 FY2026 results: revenue $38 million, net income $12 millionhttps://greeksoup.ai/stocks/us/eton/results/fy2026-q2/us:ETON:result:2026-08-13:cea8faa8d4Thu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 10-Q: form 10-qhttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-08-13:7c8bf39482Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-08-13:c52fc0242fThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 8-K: material agreement, acquisition or disposition completedhttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-08-05:6fb55fa67fWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Eton Pharmaceuticals, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/eton/filings/us:ETON:filing:2026-08-04:583dcdc0d0Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>